Pauline Vachin

CMIP is a negative regulator of T cell signaling

G. Astarita, I. Guerrera, A. Pawlak, 2019, Cellular & Molecular Immunology.

NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome.

D. Sahali, A. Pawlak, M. Ollero, 2017, Journal of autoimmunity.

Repression of CMIP transcription by WT1 is relevant to podocyte health.

A. Schedl, M. Eccles, A. Moktefi, 2016, Kidney international.

Segregation of mitochondrial DNA mutations in the human placenta: implication for prenatal diagnosis of mtDNA disorders

A. Munnich, Y. Ville, C. Elie, 2017, Journal of Medical Genetics.